Covered recipient · General Payments record
KATHERINE CREGOR
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$1,761.74
- Reported across 104 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $348.35 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $152.01 | 8 |
| Amgen Inc. | $52.46 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $44.12 | 2 |
| Regeneron Healthcare Solutions, Inc. | $24.36 | 1 |
| E.R. Squibb & Sons, L.L.C. | $21.98 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $18.13 | 1 |
| Sandoz Inc. | $18.01 | 1 |
| Lilly USA, LLC | $17.28 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.57 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106965733 | CMS |
| ABBVIE INC. | $17.09 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106965735 | CMS |
| ABBVIE INC. | $22.20 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106965737 | CMS |
| ABBVIE INC. | $17.35 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106965739 | CMS |
| ABBVIE INC. | $19.04 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106965741 | CMS |
| ABBVIE INC. | $13.94 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106965743 | CMS |
| ABBVIE INC. | $27.11 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106965745 | CMS |
| ABBVIE INC. | $26.71 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106965747 | CMS |
| Amgen Inc. | $26.38 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117533574 | CMS |
| Amgen Inc. | $26.08 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117533576 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $22.54 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118199050 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.58 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118199045 | CMS |
| E.R. Squibb & Sons, L.L.C. | $21.98 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101463569 | CMS |
| Lilly USA, LLC | $17.28 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135728093 | CMS |
| Novartis Pharmaceuticals Corporation | $18.13 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086660049 | CMS |
| Regeneron Healthcare Solutions, Inc. | $24.36 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114288595 | CMS |
| Sandoz Inc. | $18.01 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089368832 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.